Tradestie Institutional Equity Comparison Engine

XRN vs CHCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CHCT Overall Edge

CHCT Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Community Healthcare Trust Incorporated Common Stock, $0.01 par value per share (CHCT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, XRN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CHCT at 37.3x Forward P/E and 28.1% operating margin (+4.4% YoY). In options structure, XRN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CHCT sits in UNCLASSIFIED (35th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CHCT
XRN N/M vs CHCT 37.3x Fwd P/E
Growth & Margin Winner CHCT
Op Margin N/A vs 28.1% ยท YoY N/A vs +4.4%
Momentum & Technical Winner CHCT
1Y -28.2% vs -1.9% ยท 52W Pos 1% vs 30%
Options & Structure Winner CHCT
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (35th %ile IV)
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
1M Return -13.02%
1Y Return -28.16%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0
CHCT NYSE
Community Healthcare Trust Incorporated Common Stock, $0.01 par value per share
Real Estate Investment Trusts
$14.52
-1.49% 1D
Market Cap $422.8M
1M Return +13.62%
1Y Return -1.89%
Forward P/E 37.3x
Unified AI Score
28.1 / 100 SELL
Tech 8.0 Fund 34.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XRN -28.16% CHCT -1.89% Spread: +17.08 pp (CHCT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XRN TTM Op. Margin: N/A CHCT TTM Op. Margin: 28.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XRN vs CHCT. Trailing 12-month operating profitability (XRN N/A vs CHCT 28.1%) and valuation multiples (XRN N/M vs CHCT 37.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XRN (1) vs CHCT (9)
Institutional Metric XRN CHCT Criterion Row Winner
Market Capitalization Scale N/A $422.8M Larger Scale CHCT
Trailing P/E Ratio Valuation N/M 20.1x Lower Multiple CHCT
Forward P/E Ratio Valuation N/M 37.3x Lower Multiple CHCT
Revenue Growth (YoY) Growth N/A +4.4% Higher Growth CHCT
Operating Margin (TTM) Profitability N/A 28.1% Higher Margin CHCT
Net Profit Margin Profitability N/A 17.8% Higher Margin CHCT
Return on Equity (ROE) Capital Efficiency N/A 5.3% Higher ROE CHCT
52-Week Range Position Momentum 1% ($26โ€“$39) 30% ($13โ€“$19) Stronger Trend CHCT
Beta / 30D Volatility Risk Regime 0.50ฮฒ ยท 47% Vol 0.19ฮฒ ยท 45% Vol Lower Realized Risk CHCT
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 28.1 / 100 (SELL) Higher Composite XRN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XRN vs CHCT Buy Guide
XRN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XRN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CHCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 35th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CHCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XRN nor CHCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.